Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cyclophosphamide

Known as: CPM, 2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide, N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active… Expand
National Institutes of Health

Related topics

Related topics

47 relations

Narrower (16)

4-methylcyclophosphamideACP protocolCEOP-B protocolCHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine
Expand
CEV regimenCFP protocolCMF-B protocolCMFVP protocol
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Mesoporous Silica Nanoparticles for Protein Protection and Delivery
Therapeutic proteins are widely used in clinic for numerous therapies such as cancer therapy, immune therapy, diabetes management… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2019
Review
2019
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial
Summary Background Biologically distinct subtypes of diffuse large B-cell lymphoma can be identified using gene-expression… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Review
2019
Review
2019
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Radiotherapy (RT) has been applied for decades as a treatment modality in the management of various types of cancer. Ionizing… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Review
2019
Review
2019
Molecularly Imprinted Polymer Based Sensors for Medical Applications
Sensors have been extensively used owing to multiple advantages, including exceptional sensing performance, user-friendly… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2018
Review
2018
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
In October 2017, the FDA granted regular approval to axicabtagene ciloleucel, a CD19-directed chimeric antigen receptor (CAR) T… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Review
2018
Review
2018
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Cancer is considered as one of the most serious health problems today. The discovery of nitrogen mustard as an alkylating agent… Expand
  • figure 8
  • figure 19
  • figure 2
  • figure 1
  • figure 2
Review
2018
Review
2018
Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective
Gut microbiota is established during birth and evolves with age, mostly maintaining the commensal relationship with the host. A… Expand
Review
2018
Review
2018
Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy
Glutamic acid decarboxylase (GAD) antibody-associated encephalitis causes both acute seizures and chronic epilepsy with… Expand
  • table 1
Review
2018
Review
2018
Soft robotic devices for hand rehabilitation and assistance: a narrative review
IntroductionThe debilitating effects on hand function from a number of a neurologic disorders has given rise to the development… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Review
2017
Review
2017
Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.
Angioimmunoblastic T-cell lymphoma (AITL) is an uncommon subtype of mature peripheral T-cell lymphoma (PTCL). The history of AITL… Expand
  • table 1
  • figure 1
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE